<DOC>
	<DOCNO>NCT01718535</DOCNO>
	<brief_summary>The Spartan FRX CYP2C19 Test System ( hereafter refer 'FRX System ' ) qualitative vitro diagnostic test identification patient 's CYP2C19 *2 , *3 *17 genotypes genomic DNA obtain buccal swab sample . This study purpose demonstrate concordance ( positive negative percent agreement ) compare Spartan FRX system bi-directional DNA sequencing . The study also evaluate concordance three different sample transport embodiment provide laboratory use transport reagent tube collect buccal sample swab laboratory .</brief_summary>
	<brief_title>Method Comparison Study Spartan FRX CYP2C19 Genotyping System Against Bi-directional Sequencing</brief_title>
	<detailed_description>The Spartan FRX CYP2C19 Test System ( hereafter refer 'FRX System ' ) qualitative vitro diagnostic test identification patient 's CYP2C19 *2 , *3 *17 genotypes genomic DNA obtain buccal swab sample . The FRX system comprise hardware consumable component . The hardware component system include Analyzer ( thermal cycler fluorescence detection capability ) , netbook computer printer . The consumable component FRX system sample collection kit . Each kit contain buccal swab ( use collect patient sample ) tube contain reagent require genomic DNA extraction PCR amplification stage test . The Spartan FRX System capable detect three CYP2C19 SNPs ( *2 , *3 , *17 ) test perform . An individual sample collection kit require SNP test ; therefore three sample collection kit require test performed system . The FRX System use trained personnel CLIA certify laboratory use buccal sample collect directly patient . The FRX CYP2C19 test intend enable clinician identify patient mutation *2 , *3 *17 locus CYP2C19 gene indicate use aid clinician determine strategy therapeutic metabolize CYP2C19 gene product . To perform test , user collect three buccal sample patient insert sample three reagent tube ( one CYP2C19 locus *2 , *3 *17 ) . The reagent tube place Analyzer FRX system automate process DNA extraction , PCR amplification , fluorescent signal detection data analysis . The system provide user print result list patient genotype *2 , *3 *17 locus . This study design demonstrate concordance ( positive negative percent agreement ) compare Spartan FRX system bi-directional DNA sequencing . The study also evaluate concordance three different sample transport embodiment provide laboratory use transport reagent tube collect buccal sample swab laboratory . For mutation , agreement FRX System bidirectional sequencing ( comparative method ) calculate : The overall accuracy test calculate report follow : - concordant result test reference method Accuracy = -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- - sample analyze reference method The first second pas result study analyzed tabulate outline table . The acceptance criterion overall study percent agreement ≥ 99.0 % second pas lower bound one-sided 95 % confidence interval use score method ≥ 95.0 % .</detailed_description>
	<criteria />
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Cyp2C19</keyword>
	<keyword>Genotyping</keyword>
	<keyword>Spartan</keyword>
	<keyword>Comparison</keyword>
	<keyword>Sequencing</keyword>
</DOC>